Asthma
Conditions
Brief summary
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
Detailed description
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no input from pharmacist) or intervention group (= with pharmaceutical care at baseline and follow-up visits over 6 months).
Interventions
PROCEDUREPharmaceutical care for asthma patients
Sponsors
University Ghent
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Patients with persistent asthma * Asthma treatment for at least 12 months * Regular visitors of the participating community pharmacy
Exclusion criteria
* Severe co-morbidity * \> 10 pack-years smoking history * Asthma Control Test score \< 15 or =25
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference between study groups in the change of asthma control from baseline and follow-up visits | after 1, 3 and 6 months |
Secondary
| Measure | Time frame |
|---|---|
| Knowledge of asthma and treatment | after 6 months |
| Asthma quality of life questionnaire (AQLQ) | after 6 months |
| Therapy adherence | — |
| Inhalation techniques | after 6 months |
| Peak flow | after 3 and 6 months |
| Asthma exacerbations | after 6 months |
| General Practitioner (GP) visits, emergency room visits and hospitalisations | — |
| Working days lost and school days lost | — |
| Smoking | after 6 months |
Countries
Belgium
Outcome results
None listed